Skip to main content
    M

    MDxHealth SA (MDXH)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.15
    +0.00 (+0.00%)

    Market Cap: $13.75M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    MDxHealth SA (MDXH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    MDxHealth SA (MDXH) has a market cap of $13.75M and an enterprise value of $78.89M. Its share count is up 90.60% from a year earlier. Its net debt of $65.14M equals 473.74% of its market cap.

    Total Valuation

    Enterprise value is 473.74% above the market cap, as debt exceeds cash.

    Market Cap$13.75M
    Enterprise Value$78.89M
    Latest price (Nov 17, 2026)$0.15

    Key Dates

    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 82.03% in the quarter ended Sep 30, 2026 and grew 42.05% a year over 2 years.

    Shares Outstanding95.42M
    Shares Change (YoY)+90.60%
    Shares Change (QoQ)+82.03%
    Share Count Growth (2Y CAGR)+42.05%

    Price Statistics

    The stock is down 95.91% over 52 weeks and trades 63.41% below its 50-day average.

    Beta (1Y)2.04
    52-Week Change-95.91%
    1-Month Change-18.67%
    3-Month Change-80.37%
    6-Month Change-82.25%
    Total Return (1Y)-95.91%
    Total Return (3Y CAGR)-63.51%
    Total Return (5Y CAGR)-57.23%
    Max Drawdown (1Y)-96.64%
    Max Drawdown (3Y)-97.21%
    Sharpe Ratio (1Y)-1.98
    Correlation with SPY (1Y)0.18
    50-Day Average$0.41
    200-Day Average$1.31
    52-Week Range$0.11 to $4.34
    RSI (14 Days)26.6
    Average Volume (20 Days)1.20M

    Price chart

    Financial Position

    Current assets cover 1.28x current liabilities.

    Current Ratio1.28x
    Quick Ratio1.10x
    Interest Coverage-1.19x

    Returns and Efficiency

    Return on invested capital is -44.75% over the last 12 months, against a 5-year average of -58.08%.

    Return on Assets (ROA)-23.96%
    Return on Invested Capital (ROIC)-44.75%
    Return on Capital Employed (ROCE)-33.94%
    ROA (5Y Average)-31.17%
    ROIC (5Y Average)-58.08%
    Asset Turnover1.08x
    Inventory Turnover10.10x
    Receivables Turnover11.88x
    Cash Conversion Cycle7 days

    Scores

    MDXH has an Altman Z-Score of -3.88, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-3.88
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $159.25M over the last 12 months is up 26.00% from the 12 months before.

    Revenue$159.25M
    Revenue Growth (YoY)+26.00%
    Gross Profit$90.54M
    Operating Income-$36.37M
    Pretax Income-$61.34M
    Net Income-$63.40M
    EBITDA-$19.55M
    EBIT-$33.47M
    Reported EPS (TTM)-$0.68

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$31.71M
    Total Debt$96.85M
    Net Debt$65.14M
    Net Debt Per Share$0.68
    Working Capital$11.40M
    Shareholder Equity-$24.54M
    Tangible Book Value-$99.07M
    Total Assets$139.91M
    Total Liabilities$164.45M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $456.00K of capital spending, operating cash flow left -$8.77M of free cash flow.

    Operating Cash Flow-$8.32M
    Capital Expenditures$456.00K
    Free Cash Flow-$8.77M
    FCF Per Share-$0.09
    Depreciation and Amortization$13.93M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -22.84%, against a 5-year average of -60.73%.

    Gross Margin56.85%
    Operating Margin-22.84%
    Pretax Margin-38.52%
    Net Margin-39.81%
    EBITDA Margin-12.28%
    EBIT Margin-21.02%
    FCF Margin-5.51%
    Gross Margin (5Y Average)56.58%
    Operating Margin (5Y Average)-60.73%
    Net Margin (5Y Average)-76.80%

    Growth

    Revenue grew 42.79% a year over 3 years.

    Revenue Growth (3Y CAGR)+42.79%
    Revenue Growth (5Y CAGR)+42.34%

    Revenue and profit by year

    Dividends and Yields

    MDXH does not pay a dividend. Its free cash flow yield is -61.71%.

    FCF Yield-61.71%
    Shareholder Yield0.00%

    Peer Position

    Against 6 similar companies, MDXH has the 6th highest ROIC.

    ROIC-44.75% vs -17.57% median
    Revenue Growth (Trailing 4 Quarters, YoY)+26.00% vs +9.78% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -2.15% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-2.15%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About MDXH

    What is MDXH's market cap?

    MDxHealth SA has a market cap of $13.75M. Its enterprise value, which adds debt and subtracts cash, is $78.89M.

    How many shares of MDXH are outstanding?

    MDxHealth SA has 95.42M shares outstanding. The count is up 90.60% from a year earlier.

    Does MDXH pay a dividend?

    No. MDxHealth SA does not pay a dividend.

    How much debt does MDXH have?

    MDxHealth SA has $96.85M of total debt and $31.71M of cash and equivalents, a net debt position of $65.14M.